Hiv Patients Comparative Study: Education to Achieve Therapeutic Viral Load Undetectable
DOI:
https://doi.org/10.52428/20756208.v11i28.613Keywords:
HIV AIDS, Antiretroviral treatment, Undetectable Viral LoadAbstract
Adherence to antiretroviral therapy (ART) with a level above 95% causes a decrease in viral load (VL) to be undetectable. Several studies showed that undetectable VL reduces the risk of HIV transmission and is the cornerstone of the strategy to end the AIDS epidemic by 2030. A VL that remains detectable or increasing implies that the person has Iow adherence to antiretroviral therapy or presents resistance, which determines the presence of opportunistic infections. The main objective of the study was to determine the efficacy of therapeutic education model (TE) on adherence to antiretroviral therapy to reach undetectable VL in patients treated at the Institute for Human Development (IDH). This was a longitudinal, quantitative, descriptive and analytical study, using a prospective cohort for monitoring patients on ART, with VL receiving or not TE at ID H from 2013 to 2015. lt was developed with people attending the outpatient clinic, who received TE sessions and others who did not receive them. 44 people were interviewed. 95,4% of people who participated in the process of TE, reached an undetectable viral load (p<0,001). The results showed the importance of the methodology to achieve an undetectable VL.
Downloads
References
1 INSTITUTO PARA EL DESARROLLO HUMANO. Guía práctica de Educación terapéutica dirigida al personal de salud, para preparar y mejorar la adherencia al tratamiento annrretrovlral. Cochabamba; 2012.
2 VERNAZZA P, HIRSCHEL B, BERNASCONI E, FLEPPD M. «Les personnes séropositives ne souffrant d'aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par vole sexuelle-. Bulletin des médecins suisses Schweizerische Árztezeitung. Bollettino dei medici svizzeri. 2008; 89:5. https://doi.org/10.4414/bms.2008.13252
3 ARIAS L, VARGAS A, RUIZ D, VALDEZ E. "La adherencia a los antirretrovirales de personas con VIH o sida en Bolivia Revista Colegio Médico de Cochabamba, Vol 22/No 1/ junio 2011, pp 9-16.
4 COMITÉ FÁRMACO TERAPÉUTICO NACIONAL ITS VIH SIDA- BOLIVIA ''Guia de terapia anttrretroviral en adultos". 2011.
5 CENSIDA, "Guia Nacional para la prevención del VIH y el sida". México 2014; 147
6 ONUSIDA. "Ending !he AIDS epidemic by 2030". Fast Track JC2686 ISBN 978-92-9253-063-t Copyright© 2014. Programa Conjunto de tas Naciones Unidas sobre el VIH/sida
7 GTT-VIH. "Se confirma la ausencia de transmisión del VIH en personas con carga vrral indetectable que toman TARGA" (gTt-VIH): disponible en: http://gtt-vih.org/actualizate/ la noticia del día 21-07-15.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Edgar Valdez Carrizo, Iván Rivera Carrasco, Marianela Ramírez Aguilar , Jhemel Garay Quiroga y Karina Rojas Gómez
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
